Drug that makes tumors glow is transforming cancer surgery
Editor's Note A new drug is giving surgeons a sharper view of cancer in the OR and helping preserve healthy tissue, Fast Company August 28 reports. Cytalux is an FDA-approved fluorescent agent that makes cancer cells glow green under infrared light, allowing surgeons to spot and remove malignant lesions with…
Robotic surgery boosts 3-year relapse-free survival in rectal cancer
Editor's Note Robotic surgery improves 3-year relapse-free survival compared with laparoscopic surgery for rectal cancer, according to findings presented at the 2025 annual meeting of the Society of American Gastrointestinal and Endoscopic Surgeons, published by Gastroenterology & Endoscopy News on August 18. As detailed in the article, researchers conducted a…
Robot surgery spans continents in FDA-backed trial
Editor's Note A Florida-based surgeon successfully performed a prostate cancer surgery on a patient in Angola—7,000 miles away—marking a major milestone in transcontinental robotic telesurgery, according to a June 17 article from ABC News. The procedure, conducted by Dr. Vipul Patel of Advent Health’s Global Robotic Institute, is reportedly the…
Study: Language barriers raise sepsis death risk despite faster treatment
Editor's Note Patients hospitalized with sepsis who have limited English proficiency (LEP) face significantly higher odds of dying in the hospital even after accounting for multiple demographic and clinical factors, according to research presented at the American Thoracic Society International Conference by researchers from UC San Diego. Healio reported the…
Study: 3D-printed models improve shared decision-making in colorectal surgery
Editor's Note Research shows using 3D-printed anatomical models during preoperative counseling can improve patients’ involvement in shared decision-making (SDM) and reduced anxiety ahead of colorectal surgery, although only the improvement in SDM met the study’s threshold for clinical significance. Published June 3 in JAMA Network Open, the single-center trial included…
Study: Blood test detects colorectal cancer but misses most precancerous polyps
Editor's Note A new blood test shows promise in detecting colorectal cancer—the second leading cause of cancer deaths in the US—but was less effective at identifying precancerous polyps, according to a June 2 announcement from Kaiser Permanente. Not yet approved by the US Food and Drug Administration, the test is…
Proposed HHS, NIH budget cuts reveal administration priorities
Editor's Note The Trump administration’s proposed fiscal year 2026 budget calls for slashing the Department of Health and Human Services (HHS) discretionary budget by $32 billion, a nearly 25% cut that brings the total to $95 billion. Fierce Healthcare reported the news June 2. Although many of the proposed cuts…
Study: Simple hysterectomy survival comparable to more radical procedures in early cervical cancer
Editor's Note Simple hysterectomy provides similar long-term survival outcomes to modified radical or radical hysterectomy for patients with low-risk, early-stage cervical cancer, according to a large cohort study published May 15 in JAMA Network Open. Consistent with prior research, the findings add to the growing body of evidence supporting conservative…
Study: Shorter radiation schedule matches safety of standard prostate cancer treatment
Editor's Note New research shows postoperative prostate cancer radiation delivered via stereotactic body radiotherapy (SBRT)—which includes just five high-dose sessions—appears as safe and tolerable as weeks-long conventional treatment. Medical Xpress reported on the findings May 15. Led by by UCLA’s Jonsson Comprehensive Cancer Center and published in JAMA Oncology, the…
Study: Fewer men undergo unnecessary prostate cancer surgery amid rise in active surveillance
Editor's Note Prostate cancer surgeries for low-risk patients have plummeted since 2010, signaling major progress in reducing overtreatment, according to an April 29 announcement from the University of Michigan. University researchers reportedly found that the proportion of men undergoing prostatectomy for Grade Group 1 prostate cancer—the lowest-risk category—dropped more than…
Free Daily News
- OR leaders must sharpen questions, partnerships as AI reshapes perioperative care
- npj Digital Surgery opens call for research on AI, robotics in the OR
- AI in the OR can sharpen skills, but humans make the lessons stick
- Endoscopy case highlights risks of complex patients in ASCs
- Robotics and AI are redefining precision in cataract surgery
- CMS plan to phase out inpatient only list sparks debate over safety for vulnerable patients
- ACS issues new best practices for managing genitourinary trauma
- Complex aortic surgery shown safe with minimally invasive approach
- Drug that makes tumors glow is transforming cancer surgery
- Surgical robotics market accelerates as new players challenge industry giants